- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥27.4b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥62.15
7D
1.6%
1Y
-24.4%
PharmaResources (Shanghai)
Market Cap: CN¥6.1b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥37.53
7D
-3.9%
1Y
23.8%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥11.5b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
300725
CN¥54.38
7D
-0.7%
1Y
18.3%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.5b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥26.78
7D
0.07%
1Y
-19.3%
AcrobiosystemsLtd
Market Cap: CN¥14.3b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥96.66
7D
9.6%
1Y
66.9%
Inner Mongolia Furui Medical Science
Market Cap: CN¥10.8b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥42.98
7D
-7.3%
1Y
-36.8%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.9b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.58
7D
-0.6%
1Y
-0.2%